Treatment and care of people with cancer is usually provided by a team of health professionals, both medical and allied health, called a multidisciplinary team.
Treatment for melanoma depends on:
- the stage of the disease
- the location of the cancer
- the severity of symptoms
- your general health and wishes.
Treatment may involve the following.
Surgery is the main initial treatment for melanoma.
Thin, early-stage melanomas can be removed by minor surgery (under local anaesthetic) that excises the tumour and some normal skin tissue around it. A wide margin of healthy skin around the edge of the tumour is removed to ensure that no cancer cells were left behind. The thicker the tumour, the wider the margin required, in terms of both area and depth. This minor surgery will leave a scar.
If the melanoma has spread to nearby lymph nodes, these lymph nodes are usually removed by surgery under general anaesthetic. This is called lymph node dissection. It will not necessarily cure the cancer, but it might prolong survival and avoid the pain resulting from the cancer growing in the lymph nodes. Removal of lymph nodes that drain fluid (lymph) from the arms or legs can cause side effects, including a buildup of fluid in the limbs.
Along with surgery, some people may receive chemotherapy.
Chemotherapy may be less effective for melanoma than for some other types of cancer. For this reason, immunotherapy and targeted therapy may be preferred. However, chemotherapy may be used to prolong survival or relieve symptoms.
Along with surgery, some people may receive radiotherapy.
Radiotherapy is not usually used to treat the original melanoma in the skin. It may be used to treat melanoma that has come back (recurred) or to kill any cancer cells remaining after surgery. It can also be used to relieve symptoms caused by spread of the melanoma, especially to the brain or bones.
Targeted therapy [link] refers to treatment with medicines that are designed to specifically attack cancer cells without harming normal cells. These types of medicines affect the way that cancer cells grow, divide, repair themselves or interact with other cells.
Medicines used for targeted therapy of melanoma include vemurafenib, dabrafenib and trametinib, which attack cells that have a damaged BRAF gene. About half of all melanomas have mutations in the BRAF gene that cause the cells to grow and divide more rapidly.
Other targeted medicines include imatinib and nilotinib, which affect melanoma cells with changes in the C-KIT gene.
Immunotherapy uses medicines to stimulate the immune system to attack cancer cells. These medicines include:
- pembrolizumab, nivolumab and ipilimumab, which block proteins on immune system cells that stop these cells from attacking other cells in the body – this boosts the immune system’s response against melanoma cells but can also cause side effects, including causing the immune system to attack other parts of the body
- cytokines, including interferon-alpha and interleukin-2, which boost the immune system generally; they can also cause side effects, some of which are serious
- Bacille–Calmette–Guerin (BCG) vaccine, which is used to vaccinate against tuberculosis and boosts the immune system generally.
Immunotherapy may be used after surgery to attack cancer cells that remain after the surgery, or it may be used to treat tumours that can’t be removed by surgery.
After treatment, you might need regular examination of the skin and lymph nodes. Depending on the stage of the melanoma when it was diagnosed and treated, you might also need imaging tests. You should also regularly examine your own skin and lymph nodes for lumps or other changes.
Stage IV melanoma, when the cancer has spread to distant organs such as the lungs or brain, is unlikely to be treatable with surgery alone. However, surgery might still be used at this stage to prolong survival and relieve symptoms. Metastases that cannot be removed by surgery may be treated with radiotherapy, immunotherapy, targeted therapy or chemotherapy. These types of treatment may shrink the tumours or slow their growth, as well as relieving symptoms.
Melanoma may recur (come back) after treatment. The cancer can recur in the skin or somewhere else in the body, and is classified as being local or distant. Secondary cancer is when the cancer spreads to another part of the body.
Treatment options for recurrent and secondary melanoma depend on where the cancer comes back, the stage of the original melanoma and the treatments that have already been tried. Treatment can include surgery (especially if the melanoma comes back in the skin near the original tumour), radiotherapy, immunotherapy, targeted therapy or chemotherapy. When the cancer comes back in organs such as the lungs, brain, bones or liver, the treatment is usually the same as for stage IV melanoma.
- American Cancer Society (2015). Melanoma skin cancer www.cancer.org/cancer/skincancer-melanoma/detailedguide/melanoma-skin-cancer-what-is-melanoma (accessed 10 April 2015).
- National Comprehensive Cancer Network (2014). NCCN guidelines for patients: melanoma, version 1.2014 http://www.nccn.org/patients/guidelines/melanoma/index.html (accessed 19 May 2015).
- National Cancer Institute (US) (2015). Melanoma treatment (PDQ®) http://www.cancer.gov/cancertopics/pdq/treatment/melanoma/Patient, patient version (accessed 10 April 2015).